<!DOCTYPE html>
<html lang="en">
<head>        <meta charset="utf-8">
        <meta name="viewport" content="width=device-width, initial-scale=1.0">    <link
        rel="stylesheet"
        href="https://maxcdn.bootstrapcdn.com/bootstrap/4.0.0/css/bootstrap.min.css"
        integrity="sha384-Gn5384xqQ1aoWXA+058RXPxPg6fy4IWvTNh0E263XmFcJlSAwiGgFAW/dAiS6JXm"
        crossorigin="anonymous"
    />
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/c3/0.6.12/c3.min.css"/>
    <style>
        h2 {
            margin-top: 35px;
        }

        html, body {
            height: 100%;
        }

        body {
            display: flex;
            flex-flow: column;
        }

        .footer {
            margin-top: auto;
            padding-top: 1em;
            background-color: #f5f5f5;
        }
    </style>    <title>WANG_RECURRENT_LIVER_CANCER_UP</title></head>

<body>
<nav class="navbar navbar-expand-lg navbar-light bg-light">
    <span class="navbar-brand">
        Molecular Signatures Database
    </span>
</nav>

<div class="container" style="margin-top: 50px; margin-bottom: 50px">
<div class="card">
        <div class="card-header">
            WANG_RECURRENT_LIVER_CANCER_UP
        </div>
        <div class="card-body">
                <p>PURPOSE: To improve the clinical management of human hepatocellular carcinoma (HCC) by accurate identification, at diagnosis, of patients at risk of recurrence after primary treatment for HCC. EXPERIMENTAL DESIGN: Two clinicopathologic variables available at diagnosis, vascular invasion and cirrhosis, together with molecular profiling using Affymetrix human HG-U133A and HG-U133B oligonucleotide probe arrays, were used to identify recurrent HCC disease. RESULTS: HCC patients presented clinically at diagnosis with vascular invasion and cirrhosis showed a high rate (78-83%) of developing recurrent disease within 6 to 35 months. In comparison, most of the HCC patients (80-100%) without vascular invasion and cirrhosis remained disease-free. However, the risk of recurrent disease for HCC patients with either vascular invasion or cirrhosis could not be accurately ascertained. Using a pool of 23 HCC patients with either vascular invasion or cirrhosis as training set, a 57-gene signature was derived and could predict recurrent disease at diagnosis, with 84% (sensitivity 86%, specificity 82%) accuracy, for a totally independent test set of 25 HCC patients with either vascular invasion or cirrhosis. On further analysis, the disease-free rate was significantly different between patients that were predicted to recur or not to recur in the test group (P = 0.002). CONCLUSION: We have presented data to show that by incorporating the status of vascular invasion and cirrhosis available at diagnosis for patients with HCC after partial curative hepatectomy and a novel 57-member gene signature, we could accurately stratify HCC patients with different risks of recurrence.</p>
            <dl>
                <dt>Local Unique Identifier</dt>
                <dd>
                    <a href="https://bioregistry.io/msigdb:M10922">M10922</a>
                </dd>

                
                
                    <dt>
                        <span class="badge badge-primary">Relation</span>
                            in taxon (<a href="https://bioregistry.io/RO:0002162"><code>RO:0002162</code></a>
)
                    </dt>
                    <dt>
                        <ul>
                                <li><a href="https://bioregistry.io/NCBITaxon:9606"><code>NCBITaxon:9606</code></a>
</li>
                        </ul>
                    </dt>
                    <dt>
                        <span class="badge badge-primary">Relation</span>
                            has part (<a href="https://bioregistry.io/BFO:0000051"><code>BFO:0000051</code></a>
)
                    </dt>
                    <dt>
                        <ul>
                                <li><a href="https://bioregistry.io/ncbigene:1069"><code>ncbigene:1069</code></a>
</li>
                                <li><a href="https://bioregistry.io/ncbigene:22834"><code>ncbigene:22834</code></a>
</li>
                                <li><a href="https://bioregistry.io/ncbigene:9144"><code>ncbigene:9144</code></a>
</li>
                                <li><a href="https://bioregistry.io/ncbigene:3775"><code>ncbigene:3775</code></a>
</li>
                                <li><a href="https://bioregistry.io/ncbigene:5781"><code>ncbigene:5781</code></a>
</li>
                                <li><a href="https://bioregistry.io/ncbigene:348235"><code>ncbigene:348235</code></a>
</li>
                                <li><a href="https://bioregistry.io/ncbigene:23518"><code>ncbigene:23518</code></a>
</li>
                                <li><a href="https://bioregistry.io/ncbigene:56288"><code>ncbigene:56288</code></a>
</li>
                                <li><a href="https://bioregistry.io/ncbigene:6747"><code>ncbigene:6747</code></a>
</li>
                                <li><a href="https://bioregistry.io/ncbigene:4736"><code>ncbigene:4736</code></a>
</li>
                                <li><a href="https://bioregistry.io/ncbigene:64750"><code>ncbigene:64750</code></a>
</li>
                                <li><a href="https://bioregistry.io/ncbigene:253461"><code>ncbigene:253461</code></a>
</li>
                                <li><a href="https://bioregistry.io/ncbigene:8450"><code>ncbigene:8450</code></a>
</li>
                                <li><a href="https://bioregistry.io/ncbigene:55285"><code>ncbigene:55285</code></a>
</li>
                                <li><a href="https://bioregistry.io/ncbigene:159090"><code>ncbigene:159090</code></a>
</li>
                                <li><a href="https://bioregistry.io/ncbigene:10083"><code>ncbigene:10083</code></a>
</li>
                                <li><a href="https://bioregistry.io/ncbigene:56904"><code>ncbigene:56904</code></a>
</li>
                                <li><a href="https://bioregistry.io/ncbigene:10198"><code>ncbigene:10198</code></a>
</li>
                                <li><a href="https://bioregistry.io/ncbigene:29127"><code>ncbigene:29127</code></a>
</li>
                                <li><a href="https://bioregistry.io/ncbigene:54431"><code>ncbigene:54431</code></a>
</li>
                        </ul>
                    </dt>
                    <dt>
                        <span class="badge badge-primary">Property</span>
                        category_code
                    </dt>
                    <dt>
                            C2
                    </dt>
                    <dt>
                        <span class="badge badge-primary">Property</span>
                        sub_category_code
                    </dt>
                    <dt>
                            CGP
                    </dt>
                    <dt>
                        <span class="badge badge-primary">Property</span>
                        contributor
                    </dt>
                    <dt>
                            Yujin Hoshida
                    </dt>
                    <dt>
                        <span class="badge badge-primary">Property</span>
                        exact_source
                    </dt>
                    <dt>
                            Fig.3A
                    </dt>
            </dl>
        </div>
    </div></div>

<footer class="footer">
    <p class="small text-center text-muted">
        Generated with PyOBO
    </p>
</footer>

<script src="https://code.jquery.com/jquery-3.2.1.slim.min.js"
        integrity="sha384-KJ3o2DKtIkvYIK3UENzmM7KCkRr/rE9/Qpg6aAZGJwFDMVNA/GpGFF93hXpG5KkN"
        crossorigin="anonymous"></script>
<script src="https://maxcdn.bootstrapcdn.com/bootstrap/4.0.0/js/bootstrap.min.js"
        integrity="sha384-JZR6Spejh4U02d8jOt6vLEHfe/JQGiRRSQQxSfFWpi1MquVdAyjUar5+76PVCmYl"
        crossorigin="anonymous"></script></body>
</html>